Generating Patient-Derived Organoid Models of Disease From Pre-treated Patients in a Clinically Certified Laboratory Setting: A Critical Step Towards Precision Medicine in Pancreatic Cancer

被引：0

作者：

Zlomke, H. ^{[1
]}

Zimmerman, J. ^{[1
]}

Seppala, T. ^{[1
]}

Suri, R. ^{[1
]}

Burns, W. ^{[1
]}

He, J. ^{[2
]}

Lafaro, K. ^{[1
]}

Shubert, C. ^{[1
]}

Wolfgang, C. L. ^{[1
]}

Zheng, L. ^{[1
]}

Burkhart, R. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1115 / 1115

页数：1

共 2 条

[1] Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer
Seppala, Toni T.
Zimmerman, Jacquelyn W.
Sereni, Elisabetta
Plenker, Dennis
Suri, Reecha
Rozich, Noah
Blair, Alex
Thomas, Dwayne L., II
Teinor, Jonathan
Javed, Ammar
Patel, Hardik
Cameron, John L.
Burns, William R.
He, Jin
Tuveson, David A.
Jaffee, Elizabeth M.
Eshleman, James
Szabolcs, Annamaria
Ryan, David P.
Ting, David T.
Wolfgang, Christopher L.
Burkhart, Richard A.
ANNALS OF SURGERY, 2020, 272 (03) : 427 - 435
[2] Commentary on "Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer"
Merchant, Nipun
ANNALS OF SURGERY, 2020, 272 (03) : 436 - 437